Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies

by Darrell O. Ricke
Published 2021-02-01

COVID-19 Disease, Women’s Predominant Non-Heparin Vaccine-Induced Thrombotic Thrombocytopenia and Kounis Syndrome: A Passepartout Cytokine Storm Interplay

by Nicholas G. Kounis, Ioanna Koniari, Cesare de Gregorio, Stelios F. Assimakopoulos, Dimitrios Velissaris, Ming-Yow Hung, Virginia Mplani, Luca Saba, Aikaterini Brinia, Sophia N. Kouni, Christos Gogos, Mattia Giovannini, Elio Novembre, Vinu Arumugham, Darrell O. Ricke, George D. Soufras, Kenneth Nugent, Piero Sestili, Robert W. Malone
Published 2021-08-01

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

by Robert W. Malone, Robert W. Malone, Philip Tisdall, Philip Fremont-Smith, Yongfeng Liu, Xi-Ping Huang, Kris M. White, Kris M. White, Lisa Miorin, Lisa Miorin, Elena Moreno, Elena Moreno, Assaf Alon, Elise Delaforge, Christopher D. Hennecker, Guanyu Wang, Joshua Pottel, Robert V. Blair, Robert V. Blair, Chad J. Roy, Chad J. Roy, Nora Smith, Julie M. Hall, Kevin M Tomera, Gideon Shapiro, Anthony Mittermaier, Andrew C. Kruse, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Bryan L. Roth, Jill Glasspool-Malone, Darrell O. Ricke
Published 2021-03-01